AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹76 Cr | ₹71 Cr | ₹72 Cr | ₹77 Cr | ₹81 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of AARTI DRUGS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹76 Cr |
Mar2023 | ₹71 Cr |
Mar2022 | ₹72 Cr |
Mar2021 | ₹77 Cr |
Mar2020 | ₹81 Cr |
How is Deferred Tax Assets / Liabilities of AARTI DRUGS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹76 Cr | 6.68 | |
Mar2023 | ₹71 Cr | -2.02 | |
Mar2022 | ₹72 Cr | -6.10 | |
Mar2021 | ₹77 Cr | -4.44 | |
Mar2020 | ₹81 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹4,129.5 Cr | 4.7% | -0.5% | -7.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | 4.7% |
-0.5% |
-7.7% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses